Research Noticeboard

Research
Monday, 12 April 2021
Call for applications: ICGEB - Collaborative Research Programme

The International Centre for Genetic Engineering and Biotechnology (ICGEB) offers a dedicated source of funding for outstanding projects in ICGEB member states, with the goal of promoting collaboration and training of young scientists as well as the development of research facilities. The ICGEB Collaborative Research Programme (CRP) is a dedicated source of funding aimed at supporting projects that address scientific problems of relevance to the host country. The programme provides support for original research projects in basic life sciences, human healthcare, industrial and agricultural biotechnology, and bioenergy.
 
Applicants for the ICGEB CRP should hold positions at Universities or Research Institutes in any of the Member States (South Africa is a member state).
 
Grants are awarded for up to three years and applicants may request a maximum annual contribution of €25,000.
 
eRA Finance Approver deadline: Tuesday, 20 April 2021
RC&I deadline: Friday, 23 April 2021
Funder due date: Saturday, 1 May 2021 at 01:59AM (SAST) (Note this is a public holiday in South Africa)
 
Further detail for this opportunity can be found here

Monday, 12 April 2021
Call for applications: Unitaid - Accelerating tools to drive tuberculosis detection

This Funding Opportunity Announcement (FOA) encourages research to enable the optimal adaptation, introduction, and placement of effective, affordable, and quality-assured innovative diagnostic solutions for tuberculosis (TB) detection that consider the integration, complementarity, and fit within the current diagnostic context in high burden countries and the linkages to care in response to the needs of affected communities. For this call, diagnostic solutions refer to diagnostic and detection devices and platforms which could include multi-disease testing platforms, digital technologies used for contact tracing and diagnosis, CAD-enabled technology, and sample collection tools and handling. In addition, solutions with demonstrated innovation and impact in response to COVID-19 or other relevant disease areas are included. Any solution proposed should have superior performance compared to currently available tools and/or enable TB detection at the point of care.
 
Applicants are encouraged to consider products that are available on the market or can be introduced in the market by no later than December 2022.
 
Support is available for up to 5 years. Unitaid anticipates funding 2-3 projects at $20-30 million.
 
eRA Finance Approver deadline: Wednesday, 12 May 2021
RC&I deadline: Monday, 17 May 2021
Funder due date: Monday, 24 May 2021 at 12:00 (SAST)

Click here for more information. 

Wednesday, 24 March 2021
Call for applications: NIH International Research Ethics Education and Curriculum Development Award

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this R25 program is to support educational activities, including courses for skills development, mentoring activities and curriculum or methods development, that foster a better understanding of biomedical, behavioural, and clinical research and its implications.
 
Grants of $230,000 direct costs per year are available for up to five years.
 
eRA Finance Approver deadline: Tuesday, 25 May 2021
RC&I deadline: Friday, 28 May 2021
NIH due date: Friday, 4 June 2021 by 17:00 (SAST)
 
Further detail for this opportunity can be found here.
 
Please complete this intention-to-submit form by 23 April 2021 if you intend applying for this call. Please note that completion of this form is for the purposes of internal support and tracking, it is not linked to funder application processes and does not commit you to applying to this opportunity.

Wednesday, 24 March 2021
Call for applications: NIH - Cellular and Molecular Biology of Complex Brain Disorders (R21)

Cellular and Molecular Biology of Complex Brain Disorders (R21) encourages research on the biology of high confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular and circuit substrates of neural function. The R21 activity code can be used for applications to develop early stage, high-risk, exploratory or proof-of-concept approaches where there is little or no preliminary data.

Grants are available for up to two years. The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.
 
eRA Finance Approver deadline: Thursday, 3 June 2021
RC&I deadline: Tuesday, 8 June 2021
NIH due date: Wednesday, 16 June 2021 at 17:00 (SAST) (note this is a public holiday in South Africa)
 
Further detail for this opportunity can be found here.
 
Please complete this FHS intention-to-submit form by 23 April 2021 if you intend applying for this call. Please note that completion of this form is for the purposes of internal support and tracking, it is not linked to funder application processes and does not commit you to applying to this opportunity.

Wednesday, 24 March 2021
Call for applications: NIH - Cellular and Molecular Biology of Complex Brain Disorders

This funding opportunity encourages research on the biology of high confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular and circuit substrates of neural function. The R01 activity code can be used for applications to further develop lines of inquiry where feasibility or proof-of-concept has been established.
 
Grants are available for up to five years with no set budget limit; however, the scope of the proposed project should determine the project period and the budget should reflect the actual needs of the proposed project.
 
eRA Finance Approver deadline: Tuesday, 25 May 2021
RC&I deadline: Friday, 28 May 2021
NIH due date: Saturday, 5 June 2021 at 17:00 (SAST) (note NIH policy for due dates falling on a weekend
 
Further detail for this opportunity can be found here.
 
Please complete this FHS intention-to-submit form by 23 April 2021 if you intend applying for this call. Please note that completion of this form is for the purposes of internal support and tracking, it is not linked to funder application processes and does not commit you to applying to this opportunity.

Wednesday, 24 March 2021
Call for applications: NIH International Bioethics Research Training Program

The International Bioethics Research Training program (D43) supports mentored doctoral and long-term postdoctoral research training for ethics experts from low- and middle-income countries (LMICs) that complements other global health research and research training programs in the mission areas of the NIH Institutes and Centers.
 
Grants of $230,000 direct costs per year are available for up to five years.
 
eRA Finance Approver deadline: Tuesday, 25 May 2021
RC&I deadline: Friday, 28 May 2021
NIH due date: Friday, 4 June 2021 by 17:00 (SAST)
 
Further detail for this opportunity can be found here
 
Please complete this intention-to-submit form by 23 April 2021 if you intend applying for this call. Please note that completion of this form is for the purposes of internal support and tracking, it is not linked to funder application processes and does not commit you to applying to this opportunity.

Wednesday, 24 March 2021
Call for applications: Complementary clinical trials - Expanding access to COVID-19 vaccines and rapid response to clinical development gaps

The Coalition for Epidemic Preparedness Innovations (CEPI) is pleased to announce a new funding opportunity of up to US $140 million, contingent upon availability of funds, for COVID-19 vaccine clinical trials. The primary objective of this direct Call for Proposals is to expand access to COVID-19 vaccines already in human trials more widely to special / sub-populations or age groups and to rapidly generate data addressing clinical development gaps of COVID-19 vaccines and platform-technologies.

NOTE: To be eligible, the COVID-19 vaccine must have entered the clinical development phase.

This Call is open for Expressions of Interest (EOIs) from January 28th, 2021 to May 28th, 2021.

Further detail for this opportunity can be found here.

Wednesday, 24 March 2021
Call for applications: NIH -Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health

Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01) funding opportunity encourages the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the FOA solicits applications for projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost technologies for preventing, detecting, diagnosing, and/or treating cancers in people living in LMICs. Applicants should have a working assay or device prototype (not necessarily already capable of cancer applications).
 
Grants are available for up to five years and applicants may request up to $475,000 in direct costs per year.
 
eRA Finance Approver deadline: Friday, 21 May 2021
RC&I deadline: Wednesday, 26 May 2021
NIH due date: Wednesday, 2 June 2021 at 17:00 (SAST)
 
Further detail for this opportunity can be found here.
 
Please complete this FHS intention-to-submit form by 28 April 2021 if you intend applying for this call. Please note that completion of this form is for the purposes of internal support and tracking, it is not linked to funder application processes and does not commit you to applying to this opportunity.

Wednesday, 24 March 2021
Call for applications: NIH - Innovation for Tuberculosis Vaccine Discovery (ITVD)

The Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) initiative supports the design of novel tuberculosis (TB) vaccine candidates that exploit innovative approaches and their advancement into preclinical animal model testing. Emphasis is placed on high risk/high impact, cutting edge strategies for TB vaccine design that incorporate novel technologies and Mycobacterium tuberculosis immunogens to expand the current global TB vaccine portfolio. This funding opportunity uses a milestone driven, biphasic award mechanism to fund high risk/exploratory research.
 
Budgets are limited to $300,000 in direct costs per year in the R61 phase and $600,000 in direct costs per year in the R33 phase. All F&A costs are excluded from this limit.
 
eRA Finance Approver deadline: Friday, 18 June 2021
RC&I deadline: Wednesday, 23 June 2021
NIH due date: Wednesday, 30 June 2021 at 17:00 (SAST)
 
Further detail for this opportunity can be found here.
 
Please complete this FHS intention-to-submit form by 19 May 2021 if you intend applying for this call. Please note that completion of this form is for the purposes of internal support and tracking, it is not linked to funder application processes and does not commit you to applying to this opportunity.

Wednesday, 24 March 2021
Call for applications: Wellcome Trust Research Fellowships for Health Professionals

The Wellcome Trust have a funding opportunity available for Research Fellowships for Health Professionals. This scheme offers practicing health professionals the opportunity to carry out humanities or social science research, in any area of health.
 
NOTE: These proposals are evaluated in a two-stage process, comprising a preliminary abstract application and invitation to submit a full application following initial funder evaluation.
 
Grants are available for up to three years and applicants may request up to £400,000, including support for salary as well as research expenses.
 
eRA Finance Approver deadline: Thursday, 10 June 2021
Funder due date: Wednesday, 16 June 2021 at 17:00 (BST) (note this is a public holiday in South Africa)

Further detail for this opportunity can be found here.

Pages

TOP